中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2013年
8期
1191-1192
,共2页
肝硬化%脾切除术%门静脉%血栓
肝硬化%脾切除術%門靜脈%血栓
간경화%비절제술%문정맥%혈전
Cirrhosis%Splenectomy%Portal vein%Thrombus
目的 分析肝炎肝硬化脾切除术后门静脉系统血栓形成的相关因素,寻找术后门静脉系统血栓的预防方法.方法 分析143例脾切除患者的临床资料,比较门静脉系统的血栓形成与患者性别、年龄、体温、门静脉直径、脾脏大小、脾脏厚度及术后血小板数量的关系.结果 门静脉系统血栓形成率为9.79％.血栓形成与患者性别、年龄、体温和脾静脉内径无关(P＞0.05),而与门静脉主干内径、脾脏厚度、脾脏大小和术后血小板计数有关(P＜0.05).结论 脾切除术后门静脉系统血栓形成与门静脉、脾静脉直径、脾脏大小有关；早期、全身应用抗凝、祛凝药能有效预防肝炎肝硬化门静脉高压症脾切除术后门静脉系统血栓的形成.
目的 分析肝炎肝硬化脾切除術後門靜脈繫統血栓形成的相關因素,尋找術後門靜脈繫統血栓的預防方法.方法 分析143例脾切除患者的臨床資料,比較門靜脈繫統的血栓形成與患者性彆、年齡、體溫、門靜脈直徑、脾髒大小、脾髒厚度及術後血小闆數量的關繫.結果 門靜脈繫統血栓形成率為9.79％.血栓形成與患者性彆、年齡、體溫和脾靜脈內徑無關(P＞0.05),而與門靜脈主榦內徑、脾髒厚度、脾髒大小和術後血小闆計數有關(P＜0.05).結論 脾切除術後門靜脈繫統血栓形成與門靜脈、脾靜脈直徑、脾髒大小有關；早期、全身應用抗凝、祛凝藥能有效預防肝炎肝硬化門靜脈高壓癥脾切除術後門靜脈繫統血栓的形成.
목적 분석간염간경화비절제술후문정맥계통혈전형성적상관인소,심조술후문정맥계통혈전적예방방법.방법 분석143례비절제환자적림상자료,비교문정맥계통적혈전형성여환자성별、년령、체온、문정맥직경、비장대소、비장후도급술후혈소판수량적관계.결과 문정맥계통혈전형성솔위9.79％.혈전형성여환자성별、년령、체온화비정맥내경무관(P＞0.05),이여문정맥주간내경、비장후도、비장대소화술후혈소판계수유관(P＜0.05).결론 비절제술후문정맥계통혈전형성여문정맥、비정맥직경、비장대소유관；조기、전신응용항응、거응약능유효예방간염간경화문정맥고압증비절제술후문정맥계통혈전적형성.
Objective To analyze the relevant factors and explore methods for prevention of portal vein thrombosis in patients after spleuectomy of portal hypertension due to cirrhosis resulted from hepatitis.Methods Clinical data of 143 patients with splenectomy weft analyze,and the relationship of portal system thrombosis with gender,age,temperature,diameter of spleen vein,average diameter of main portal vein,size of spleen,thickness of spleen and number of thrombocytes after operation were compared.Results The results showed that the rate of portal hypertension was 9.79％.The thrombosis of portal vein was related to the average diameter of main portal vein,size of spleen,thickness of spleen and number of thrombocytes after operation (P ＜ 0.05),other than related to the gender,age,temperature and the diameter of spleen vein (P ＞ 0.05).Conclusion The portal vein thrombosis in patients after splenectomy is related to portal vein,diameter of spleen vein and size of the spleen.Anticoagulation therapy given in the early stage can prevent the occurrence of the portal system thrombosis in patients with liver cirrhosis and portal hypertension after splenectomy.
